IHT Wealth Management’s Bioverativ Inc. Common Stock BIVV Stock Holding History

IHT Wealth Management’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-103	Closed	-$6K	–	1811
2017 Q4	$6K	Sell	103 -21	-17%	-$1.15K	﹤0.01%	1315
2017 Q3	$7K	Buy	124 +34	+38%	+$1.99K	﹤0.01%	1044
2017 Q2	$12	Buy	90 +16	+22%	+$911	0.01%	936
2017 Q1	$4K	Buy	+74	New	+$3.65K	﹤0.01%	1007

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

IHT Wealth Management's BIVV Position: Q1 2018 in Review

IHT Wealth Management sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 103 shares — an estimated $6K sold.

IHT Wealth Management first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $7K in Q3 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

IHT Wealth Management reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
IHT Wealth Management sold 103 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $6K.
IHT Wealth Management first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
IHT Wealth Management's Bioverativ Inc. Common Stock position peaked at $7K in Q3 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on IHT Wealth Management's 13F filing for Q1 2018, filed 15 May 2018.